Researchers from the University of Turku and Turku University Hospital, Finland, led by Docent Sami Ventelä and Professor ...

Post-operative chemoradiation improved survival but raised non-cancer mortality. Researchers conducted a retrospective study ...

Following a head and neck cancer diagnosis, you may want to ask the doctor about available treatment options, what treatments are recommended, which have the best survival rates, and the quality ...

Head and neck squamous cell carcinomas (HNSCC) are a group of cancers that affect cells in and around our mouth and nose.

Survival With Less Treatment Dr. Lee has led multiple studies showing that some head and neck cancers can be successfully treated with reduced radiation doses. This technique has already changed ...

In the PD-L1 CPS ≥ 1 population, 3-year event-free survival was 58.2% in the pembrolizumab group vs 44.9% in the standard of care group (HR, 0.70; P = .0014).

To pinpoint those needs, Northwestern scientists surveyed 317 head‑and‑neck cancer survivors treated with radiation and other therapies from 2013 to 2023.

Keytruda reduced the risk of recurrence, progression, or death by 30% vs. standard of care in HNSCC patients. Median event-free survival was 59.7 months with Keytruda vs. 29.6 months with standard ...

Head and neck cancer and its treatments may affect speech, swallowing, or other functions. Your care team may recommend different types of rehabilitation therapy and techniques to aid your recovery.

Neoadjuvant combination immunotherapy may improve survival compared with single-agent therapy for patients with head and neck squamous cell carcinoma, according to results of a randomized phase 2 ...

The two phase 2 studies, presented at the 2024 American Society for Radiation Oncology (ASTRO) Head and Neck Cancer Symposium on March 1, 2024, found an increase in 1-year local control rate ...

Ravindra Uppaluri, MD, PhD, lead investigator of the phase 3 KEYNOTE-689 trial (NCT03765918), highlights the potential of pembrolizumab (Keytruda; Merck) to improve outcomes following head and ...